PPAR γ agonists, including the thiazolidinedione derivatives rosiglitazone, pioglitazone, and troglitazone, attenuate cancer-induced body weight wasting and TNF-α-induced adipocyte wasting [19,20,21,22]. The gene discussed is TNF; the disease is cancer.